Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2005

01-06-2005 | Poster Presentation

Identification of clinically relevant gene sets and pathways using functional models of breast tumor suppression

Authors: S Seitz, E Korsching, J Weimer, A Jacobsen, N Arnold, A Meindl, W Arnold, D Gustavus, C Klebig, I Petersen, S Scherneck

Published in: Breast Cancer Research | Special Issue 2/2005

Login to get access

Excerpt

Several lines of evidence suggest that chromosome 8 is likely to harbor tumor suppressor gene(s) involved in breast cancer. We have shown previously that microcell-mediated transfer of human chromosome 8 into the breast cancer cell line MDA-MB-231 results in reversion of tumorigenicity of these cells and is accompanied by expression changes of a clinically relevant set of genes. …
Metadata
Title
Identification of clinically relevant gene sets and pathways using functional models of breast tumor suppression
Authors
S Seitz
E Korsching
J Weimer
A Jacobsen
N Arnold
A Meindl
W Arnold
D Gustavus
C Klebig
I Petersen
S Scherneck
Publication date
01-06-2005
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2005
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1143

Other articles of this Special Issue 2/2005

Breast Cancer Research 2/2005 Go to the issue

Oral Presentation

Stromal and epithelial TGF-β signaling in mammary tumorigenesis

Poster Presentation

Who gets cancer?

Poster Presentation

Lack of evidence for nuclear IGFBP5 in mammary epithelial cells

Poster Presentation

Characterization of extracellular matrix composition in breast carcinoma

Poster Presentation

Genome-wide expression profiling of microdissected human breast tumor cells: tumor classification predictive of metastases and clinical outcome

Poster Presentation

HER2 and ERβ2 downregulate estrogen-responsive element-mediated transcription activity of ERα-positive cells in response to estrogen stimulation
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits